This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Theracosbio, LLC. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovations of Chunfeng Dai
Introduction
Chunfeng Dai is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of medications. His innovative approach has the potential to enhance the effectiveness of existing drugs while minimizing side effects.
Latest Patents
Chunfeng Dai holds 1 patent related to pharmaceutical formulations. His patent focuses on the pharmacokinetic profile of the SGLT2 inhibitor bexagliflozin. By formulating it as an extended-release tablet, he has demonstrated that it can improve the drug's performance. Compared to standard immediate-release dosage forms, these tablets allow for a lower peak plasma concentration while maintaining therapeutic levels for a desired period. This advancement can enable the administration of lower doses while still achieving the same pharmacological effect.
Career Highlights
Chunfeng Dai is currently associated with Theracosbio, LLC, where he continues to work on innovative pharmaceutical solutions. His expertise in drug formulation has positioned him as a valuable asset in the industry. His work is characterized by a commitment to improving patient outcomes through scientific innovation.
Collaborations
Chunfeng collaborates with talented individuals such as Feng Wang and Ankit Shrivastava. Their combined efforts contribute to the advancement of pharmaceutical research and development.
Conclusion
Chunfeng Dai's contributions to pharmaceutical formulations exemplify the impact of innovation in medicine. His work not only enhances drug efficacy but also prioritizes patient safety and comfort.